Page last updated: 2024-08-18

dimethyldioctadecylammonium and HIV

dimethyldioctadecylammonium has been researched along with HIV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agger, EM; Andersen, P; Berzofsky, JA; Billeskov, R; Frey, B; Kulkarni, S; Solaymani-Mohammadi, S; Sui, Y; Wang, Y1

Other Studies

1 other study(ies) available for dimethyldioctadecylammonium and HIV

ArticleYear
Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.
    Journal of immunology (Baltimore, Md. : 1950), 2017, 05-01, Volume: 198, Issue:9

    Topics: Adjuvants, Immunologic; AIDS Vaccines; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; HIV; HIV Antigens; Humans; Liposomes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monoglycerides; Poly I-C; Quaternary Ammonium Compounds

2017